Stock Analysis
CVS Health Corp. (CVS) Stock Analysis
CVS Health Corp. (CVS) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
CVS Health Corp. (CVS) currently has an AIQ Score of 51/100, indicating a neutral setup. Sentiment is the strongest factor at 77/100. Quality is the weakest current factor at 28/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CVS at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $94.66 |
| AIQ Score | 51/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $124.53B |
| P/E Ratio | 12.45 |
| Forward P/E | — |
| EPS | $2.33 |
| Revenue TTM | $106.1B |
| Dividend Yield | 0.01% |
| Beta | 0.6 |
| Volume | 4.38M |
| 52-week range | $69.51-$110.68 |
| RSI 14 | 56.44 |
| 50-Day SMA | $100.10 |
| 200-Day SMA | $86.92 |
| Analyst Price Target | $109.71 |
| Next Earnings | Nov 4, 2026 |
CVS
OverviewCVS Stock Analysis Summary
CVS Health Corp. (CVS) currently has an AIQ Score of 51/100, indicating a neutral setup. Sentiment is the strongest factor at 77/100. Quality is the weakest current factor at 28/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CVS has AIQ Score of 51/100 with Sentiment base of 77/100 and fading Quality at 28/100. Wait for component alignment before adding exposure.
Sentiment (77/100) leads while Quality (28/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.66% stock move · CVS classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CVS Bullish or Bearish Right Now?
CVS currently has a neutral overall setup. Sentiment is the strongest factor at 77/100, while Quality is weakest at 28/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Analyst target implies +15.90% upside from the latest quote.
- - Technical consensus has more sell votes than buy votes (29 vs 9).
Current Consensus
CVS's Technical Analysis Consensus is currently Sell, with 9 buy, 7 neutral, and 29 sell votes. CVS's 14-day RSI is 56.44, which places the stock in a constructive momentum range. CVS's beta is 0.6, indicating lower market sensitivity than the broad market.
What Changed in CVS?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the CVS Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CVS Decision Framework
Public evidence layers, setup checks, and risk context for CVS Health Corp..
CVS Health Corp. (CVS) Stock Analysis
CVS Health Corp. has an AIQ Score of 51/100 in a Neutral regime. Sentiment is strongest at 77/100. Beta is 0.6, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CVS is in a Neutral AIQ regime with score 51/100. |
| Signal Conflict | The primary conflict is that sentiment leads at 77/100 while quality lags at 28/100. |
| Factor Evidence | Momentum 55/100 · Value 70/100 · Quality 28/100 · Risk 53/100 · Sentiment 77/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Sentiment is the strongest factor at 77/100.
Momentum is 55/100 and RSI (14) is 56.4.
CVS is in a Neutral regime at 51/100.
Risk factor is 53/100 with beta 0.6 and annual volatility 30.62%.
Current conflict: sentiment leads at 77/100 while quality lags at 28/100.
CVS Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CVS Fundamentals
CVS valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CVS Technical Analysis
CVS technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CVS Stock Catalysts
Track CVS earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CVS Dividend Analysis
CVS dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CVS Financial Data
CVS revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CVS Risk Analysis
CVS volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CVS Stock News
CVS stock news, market tone, recent headlines, and catalyst context.
CVS vs Healthcare Services / Managed Care Peers
Current peer cohort: CVS · DGX · DOCS · DVA · EHC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| CVS Current stock | 51/100 | 70/100 | 55/100 | 53/100 | 0.84 | 30.62% | Current |
| DGX Quest Diagnostics | 50/100 | 53/100 | 42/100 | 60/100 | 1.07 | 23.85% | CVS vs DGX |
| DOCS Doximity | 59/100 | 46/100 | 55/100 | 56/100 | -1.31 | 63.74% | CVS vs DOCS |
| DVA DaVita | 59/100 | 68/100 | 66/100 | 57/100 | 0.83 | 45.08% | CVS vs DVA |
| EHC Encompass Health | 63/100 | 57/100 | 65/100 | 60/100 | -0.08 | 28.80% | CVS vs EHC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CVS
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CVS
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CVS Stock FAQ
What is CVS stock price today?
CVS Health Corp.'s current stock price is $94.66. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CVS bullish or bearish right now?
CVS's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CVS's market cap?
CVS's market cap is $124.53B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CVS's current P/E ratio?
CVS's current P/E ratio is 12.45 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CVS's RSI?
CVS's 14-day RSI is 56.44 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CVS above its 50-day and 200-day moving averages?
CVS is -5.43% from its 50-day SMA and 8.91% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CVS's next earnings date?
CVS's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CVS pay a dividend?
CVS's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.